These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 8770429

  • 1. Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients.
    Abel KM, O'Keane V, Murray RM.
    Br J Psychiatry; 1996 Jan; 168(1):57-60. PubMed ID: 8770429
    [Abstract] [Full Text] [Related]

  • 2. Serotonergic function and negative and depressive symptomatology in schizophrenia and major depression.
    Abel KM, O'Keane V, Murray RM, Cleare AJ.
    Psychoneuroendocrinology; 1997 Oct; 22(7):539-48. PubMed ID: 9373887
    [Abstract] [Full Text] [Related]

  • 3. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V, Dinan TG.
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [Abstract] [Full Text] [Related]

  • 4. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
    Maes M, Jacobs MP, Suy E, Minner B, Raus J.
    Neuropsychobiology; 1989 Aug; 21(4):192-6. PubMed ID: 2561010
    [Abstract] [Full Text] [Related]

  • 5. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.
    Lerer B, Gillon D, Lichtenberg P, Gorfine M, Gelfin Y, Shapira B.
    Int Psychogeriatr; 1996 Aug; 8(1):83-102. PubMed ID: 8805090
    [Abstract] [Full Text] [Related]

  • 6. Prolactin and cortisol responses to fenfluramine in Parkinson's disease.
    Kostić VS, Lecić D, Doder M, Marinković J, Filipović S.
    Biol Psychiatry; 1996 Oct 15; 40(8):769-75. PubMed ID: 8894070
    [Abstract] [Full Text] [Related]

  • 7. Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests.
    Duval F, Mokrani MC, Monreal J, Bailey P, Valdebenito M, Crocq MA, Macher JP.
    Psychoneuroendocrinology; 2003 Jul 15; 28(5):627-42. PubMed ID: 12727131
    [Abstract] [Full Text] [Related]

  • 8. Hormonal responses to fenfluramine in depressive subtypes.
    Mitchell P, Smythe G, Parker G, Wilhelm K, Hickie I, Brodaty H, Boyce P.
    Br J Psychiatry; 1990 Oct 15; 157():551-7. PubMed ID: 2131137
    [Abstract] [Full Text] [Related]

  • 9. Hormonal responses to fenfluramine in depressed and control subjects.
    Mitchell P, Smythe G.
    J Affect Disord; 1990 May 15; 19(1):43-51. PubMed ID: 2140846
    [Abstract] [Full Text] [Related]

  • 10. Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response.
    Cleare AJ, Murray RM, O'Keane V.
    Biol Psychiatry; 1998 Oct 01; 44(7):555-61. PubMed ID: 9787879
    [Abstract] [Full Text] [Related]

  • 11. Serotonergic function and suicidal behavior in schizophrenia.
    Corrêa H, Duval F, Mokrani MC, Bailey P, Trémeau F, Staner L, Diep TS, Crocq MA, Macher JP.
    Schizophr Res; 2002 Jul 01; 56(1-2):75-85. PubMed ID: 12084422
    [Abstract] [Full Text] [Related]

  • 12. Hormone responses to fenfluramine and placebo challenge in endogenous depression.
    Lichtenberg P, Shapira B, Gillon D, Kindler S, Cooper TB, Newman ME, Lerer B.
    Psychiatry Res; 1992 Aug 01; 43(2):137-46. PubMed ID: 1410069
    [Abstract] [Full Text] [Related]

  • 13. Effect of clozapine on d-fenfluramine-evoked neuroendocrine responses in schizophrenia and its relationship to clinical improvement.
    Curtis VA, Wright P, Reveley A, Kerwin R, Lucey JV.
    Br J Psychiatry; 1995 May 01; 166(5):642-6. PubMed ID: 7620750
    [Abstract] [Full Text] [Related]

  • 14. The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit.
    Lucey JV, Butcher G, Clare AW, Dinan TG.
    Acta Psychiatr Scand; 1993 Jun 01; 87(6):384-8. PubMed ID: 8356888
    [Abstract] [Full Text] [Related]

  • 15. Abnormal behavioral responses to fenfluramine in patients with affective and personality disorders. Correlation with increased serotonergic responsivity.
    Myers JE, Mieczkowski T, Perel J, Abbondanza D, Cooper TB, Mann JJ.
    Biol Psychiatry; 1994 Jan 15; 35(2):112-20. PubMed ID: 8167207
    [Abstract] [Full Text] [Related]

  • 16. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
    O'Keane V, McLoughlin D, Dinan TG.
    J Affect Disord; 1992 Nov 15; 26(3):143-50. PubMed ID: 1460163
    [Abstract] [Full Text] [Related]

  • 17. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
    Lucey JV, O'Keane V, Butcher G, Clare AW, Dinan TG.
    Br J Psychiatry; 1992 Oct 15; 161():517-21. PubMed ID: 1393339
    [Abstract] [Full Text] [Related]

  • 18. Serotonergic function in panic disorder: endocrine responses to D-fenfluramine.
    Judd FK, Apostolopoulos M, Burrows GD, Norman TR.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar 15; 18(2):329-37. PubMed ID: 8208982
    [Abstract] [Full Text] [Related]

  • 19. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia.
    Krystal JH, Seibyl JP, Price LH, Woods SW, Heninger GR, Aghajanian GK, Charney DS.
    Arch Gen Psychiatry; 1993 Aug 15; 50(8):624-35. PubMed ID: 8102048
    [Abstract] [Full Text] [Related]

  • 20. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression.
    Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S.
    Life Sci; 1984 Mar 12; 34(11):1029-39. PubMed ID: 6700367
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.